Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1975 Feb;30(1):86–90. doi: 10.1136/thx.30.1.86

Incidence of paramalignant disorders in bronchogenic carcinoma.

J W Rassam, G Anderson
PMCID: PMC470249  PMID: 164704

Abstract

The incidence of paramalignant disorders was studied in 280 consecutive patients with early lung cancer confirmed histologically. The commonest disorders were weight loss exceeding 6.4 kg (30.7 percent of the series), finger clubbing (29 percent), fever (21.1 percent), and endocrinopathies (12.1 percent). Paramalignant diseases are common even in early lung cancer and all patients should have investigations for their detection.

Full text

PDF
86

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azzopardi J. G., Freeman E., Poole G. Endocrine and metabolic disordes in bronchial carcinoma. Br Med J. 1970 Nov 28;4(5734):528–530. doi: 10.1136/bmj.4.5734.528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Azzopardi J. G., Whittaker R. S. Bronchial carcinoma and hypercalcaemia. J Clin Pathol. 1969 Nov;22(6):718–724. doi: 10.1136/jcp.22.6.718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. CROFT P. B., WILKINSON M. Carcinomatous neuromyopathy. Its incidence in patients with carcinoma of the lung and carcinoma of the breast. Lancet. 1963 Jan 26;1(7274):184–188. doi: 10.1016/s0140-6736(63)91208-x. [DOI] [PubMed] [Google Scholar]
  4. Carey V. C. The incidence of hypercalcemia in association with bronchogenic carcinoma. Am Rev Respir Dis. 1966 Apr;93(4):584–586. doi: 10.1164/arrd.1966.93.4.584. [DOI] [PubMed] [Google Scholar]
  5. Eliakim M., Pinchas S. Degenerative verrucous endocardiosis. A clinical-pathological study of 45 cases with reference to a protracted form of the disease. Isr J Med Sci. 1966 Jan-Feb;2(1):42–51. [PubMed] [Google Scholar]
  6. GLICKSMAN A. S., RAWSON R. W. Diabetes and altered carbohydrate metabolism in patients with cancer. Cancer. 1956 Nov-Dec;9(6):1127–1134. doi: 10.1002/1097-0142(195611/12)9:6<1127::aid-cncr2820090610>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  7. GRAHAM J. H., HELWIG E. B. Bowen's disease and its relationship to systemic cancer. AMA Arch Derm. 1959 Aug;80(2):133–159. doi: 10.1001/archderm.1959.01560200001001. [DOI] [PubMed] [Google Scholar]
  8. HATCH H. B., Jr, SEGALOFF A., OCHSNER A. ADRENOCORTICAL FUNCTION IN BRONCHOGENIC CARCINOMA: STUDY OF 100 PATIENTS. Ann Surg. 1965 May;161:645–648. doi: 10.1097/00000658-196505000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. RAMAH S. J., CHOMET B. Bronchogenic carcinoma and peptic ulcer. Cancer. 1962 Nov-Dec;15:1117–1118. doi: 10.1002/1097-0142(196211/12)15:6<1117::aid-cncr2820150604>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  10. SEMPLE T., McCLUSKIE R. A. Generalized hypertrophic osteoarthropathy in association with bronchial carcinoma; a review, based on 24 cases. Br Med J. 1955 Mar 26;1(4916):754–759. doi: 10.1136/bmj.1.4916.754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Soong B. C., Miller S. P. Coagulation disorders in cancer. 3. Fibrinolysis and inhibitors. Cancer. 1970 Apr;25(4):867–874. doi: 10.1002/1097-0142(197004)25:4<867::aid-cncr2820250417>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  12. de GENNES, BRICAIRE H., LEPRAT J. [Paraneoplastic endocrine syndromes. II. Hyperthyroidism and various endocrinopathies]. Presse Med. 1962 Oct 27;70:2137–2139. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES